EP 1000055 A1 20000517 - SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
Title (en)
SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
Title (de)
SUBSTITUIERTE PYRAZOLE ALS P38-KINASE-INHIBITOREN
Title (fr)
PYRAZOLES SUBSTITUES UTILISES COMME INHIBITEURS DE p38 KINASE
Publication
Application
Priority
- US 9810436 W 19980522
- US 4757097 P 19970522
Abstract (en)
[origin: WO9852940A1] A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula (I) wherein R<1>, R<2>, R<3> and R<4> are as described in the specification.
IPC 1-7
C07D 401/04; A61K 31/415; A61K 31/44; A61K 31/505; C07D 401/14; C07D 409/14; C07D 413/14; C07D 405/14; C07D 471/04; C07D 417/14; C07D 453/02
IPC 8 full level
A61K 31/4155 (2006.01); A61K 31/422 (2006.01); A61K 31/427 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/498 (2006.01); A61K 31/506 (2006.01); A61K 31/52 (2006.01); A61K 31/5377 (2006.01); C07D 473/00 (2006.01); A61P 1/04 (2006.01); A61P 3/14 (2006.01); A61P 7/02 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 19/06 (2006.01); A61P 29/00 (2006.01); A61P 37/06 (2006.01); A61P 43/00 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 405/14 (2006.01); C07D 409/04 (2006.01); C07D 409/14 (2006.01); C07D 413/04 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01); C07D 451/02 (2006.01); C07D 453/02 (2006.01); C07D 471/04 (2006.01)
CPC (source: EP KR)
A61P 1/04 (2018.01 - EP); A61P 3/14 (2018.01 - EP); A61P 7/02 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 11/00 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 17/06 (2018.01 - EP); A61P 19/00 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 19/06 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 31/00 (2018.01 - EP); A61P 37/06 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 401/04 (2013.01 - EP KR); C07D 401/14 (2013.01 - EP); C07D 403/04 (2013.01 - EP); C07D 405/14 (2013.01 - EP); C07D 409/14 (2013.01 - EP); C07D 413/14 (2013.01 - EP); C07D 417/14 (2013.01 - EP); C07D 453/02 (2013.01 - EP); C07D 471/04 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9852940 A1 19981126; AP 1246 A 20040207; AP 9901715 A0 19991231; AU 754830 B2 20021128; AU 754830 C 20040212; AU 7588398 A 19981211; BG 103964 A 20000831; BG 64313 B1 20040930; BR 9809147 A 20000801; CA 2291115 A1 19981126; CN 1264377 A 20000823; EA 003925 B1 20031030; EA 199900953 A1 20001030; EE 9900527 A 20000615; EP 1000055 A1 20000517; GE P20033053 B 20030825; HU P0001880 A2 20010328; HU P0001880 A3 20020328; ID 22982 A 19991223; IL 132991 A0 20010319; IL 132991 A 20051120; IS 5257 A 19991119; JP 2002508754 A 20020319; KR 20010012854 A 20010226; NO 995695 D0 19991119; NO 995695 L 20000121; NZ 501112 A 20021025; OA 12981 A 20061013; PL 337020 A1 20000731; SK 157899 A3 20000814; TR 200000235 T2 20000522; ZA 984358 B 19990524
DOCDB simple family (application)
US 9810436 W 19980522; AP 9901715 A 19980522; AU 7588398 A 19980522; BG 10396499 A 19991208; BR 9809147 A 19980522; CA 2291115 A 19980522; CN 98807369 A 19980522; EA 199900953 A 19980522; EE P9900527 A 19980522; EP 98923642 A 19980522; GE AP1998005095 A 19980522; HU P0001880 A 19980522; ID 991425 A 19980522; IL 13299198 A 19980522; IS 5257 A 19991119; JP 55065098 A 19980522; KR 19997010820 A 19980522; NO 995695 A 19991119; NZ 50111298 A 19980522; OA 9900252 A 19991122; PL 33702098 A 19980522; SK 157899 A 19980522; TR 200000235 T 19980522; ZA 984358 A 19980522